Elanco Animal Health Inc

ELAN NYSE SEC CIK 1739104
Follow Elanco Animal Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.3B +11.3% vs same quarter last year
Net income $18M +152.9% vs same quarter last year
EPS, diluted $0.04 +157.1% vs same quarter last year
Operating cash flow $216M −1.4% vs same quarter last year
Revenue by quarter
$1B
$1.2B
$1.2B
$1.1B
$1.1B
$1.4B
$1.4B
$1.3B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$2B$0$2B$4B$6BFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.7B−$232M
FY24$4.4B$338M
FY23$4.4B−$1.2B
FY22$4.4B−$78M
FY21$4.8B−$483M
FY20$3.3B−$574M
FY19$3.1B$68M
FY18$3.1B$86.5M
FY17$2.9B−$310.7M
FY16$2.9B−$47.9M
FY15--
MarginsShare of revenue
  • Gross margin
  • Net margin
−50%−25%0%25%50%75%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginNet margin
FY2555%−4.9%
FY2454.9%7.6%
FY2356.3%−27.9%
FY2256.6%−1.8%
FY2155.2%−10.1%
FY2049.1%−17.5%
FY1952.1%2.2%
FY1848.7%2.8%
FY1748.3%−10.8%
FY1651.6%−1.6%
FY15--
Free cash flowOperating cash flow minus capital expenditure
−$200M$0$200M$400MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$284M
FY24$394M
FY23$131M
FY22$281M
FY21$324M
FY20−$176M
FY19$84M
FY18$352.8M
FY17$75.2M
FY16$45.6M
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Elanco Animal Health
  • Healthcare median
−100%−75%−50%−25%0%25%FY15FY17FY19FY21FY23FY25
Show the numbers
YearElanco Animal HealthHealthcare median
FY25−4.9%−30.6%
FY247.6%−47%
FY23−27.9%−58%
FY22−1.8%−80.4%
FY21−10.1%−71.9%
FY20−17.5%−62.2%
FY192.2%−46.3%
FY182.8%−49.6%
FY17−10.8%−45.9%
FY16−1.6%−36%
FY15-−38.4%